Latest filing published 19 Aug 2026 for Sotera Health Co, €4.7M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael B. Petras Jr., listed as chief executive, appears in our data through filings on Sotera Health Co shares, published by SEC (Form 4). We count 33 filings; the first trade dates from 20 November 2020 and the latest from 17 August 2026.
No open-market purchase appears, only 7 sales worth €60.1M. Other entries cover 20 share grants and 1 option exercise. So far in 2026, the count stands at no purchases and 2 sales.
Most recently, on 19 August 2026, the filings show an open-market sale worth €4.7M in Sotera Health Co. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations